Ueno et al. first prospectively assessed the role of age in EGFR mutations in 1262 patients with lung cancer and demonstrated that only 30% of patients carrying EGFR mutations were under 45 years, compared with 70% over 65 years age.7 This evidence concerns the gene EGFR and lung cancer.